Passage Bio, Inc.
PASG
$7.48
-$0.065-0.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -25.72% | 29.14% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.24% | -3.14% | |||
| Operating Income | 25.24% | 3.14% | |||
| Income Before Tax | 39.08% | -21.06% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.08% | -21.06% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.08% | -21.06% | |||
| EBIT | 25.24% | 3.14% | |||
| EBITDA | 25.37% | -0.52% | |||
| EPS Basic | 40.30% | -20.57% | |||
| Normalized Basic EPS | 27.97% | 0.07% | |||
| EPS Diluted | 40.30% | -20.57% | |||
| Normalized Diluted EPS | 27.97% | 0.07% | |||
| Average Basic Shares Outstanding | 2.04% | 0.41% | |||
| Average Diluted Shares Outstanding | 2.04% | 0.41% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||